Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sukhbinder Dhesy-Thind

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
JAMA Network Open|January 16, 2019
Human Papillomavirus Status and Esophageal Adenocarcinoma: Worth a Closer Look?Sukhbinder Dhesy-Thind
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Cardiac troponin cutoffs: the importance of assay sensitivity and the patient populationPeter A Kavsak, Sukhbinder Dhesy-Thind
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 11, 2005
Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update)Eva Grunfeld, Sukhbinder Dhesy-Thind, Mark Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2012
Is colon cancer survival influenced by tumor location?Brandon M Meyers, Sukhbinder Dhesy-Thind, Kevin Zbuk
Journal of Reproductive Immunology|July 1, 2015
The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in peri-implant decidua by 5 weeks' gestationDavid A Clark, Jorge L Arredondo, Sukhbinder Dhesy-Thind
Journal of Reproductive Immunology|June 12, 2016
Corrigendum to "The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in peri-implant decidua by 5 weeks' gestation" [J. Reprod. Immunol. 112 (2015) 20-23]David A Clark, Jorge L Arredondo, Sukhbinder Dhesy-Thind
Clinical Chemistry and Laboratory Medicine|December 8, 2024
Concentrations and agreement over 10 years with different assay versions and analyzers for troponin T and N-terminal pro-B-type natriuretic peptidePeter A Kavsak, Lorna Clark, Andrew Worster, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 22, 2014
The CD200-tolerance signaling molecule associated with pregnancy success is present in patients with early-stage breast cancer but does not favor nodal metastasisDavid A Clark, Sukhbinder Dhesy-Thind, Peter Ellis, et al.
The Breast Journal|July 3, 2019
Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical OncologistsElysia Donovan, Sukhbinder Dhesy-Thind, Som Mukherjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2017
Reply to T.J. Powles et alSukhbinder Dhesy-Thind, Glenn G Fletcher, Mark Clemons, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
JAMA Network Open|January 16, 2019
Human Papillomavirus Status and Esophageal Adenocarcinoma: Worth a Closer Look?Sukhbinder Dhesy-Thind
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Cardiac troponin cutoffs: the importance of assay sensitivity and the patient populationPeter A Kavsak, Sukhbinder Dhesy-Thind
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 11, 2005
Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update)Eva Grunfeld, Sukhbinder Dhesy-Thind, Mark Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2012
Is colon cancer survival influenced by tumor location?Brandon M Meyers, Sukhbinder Dhesy-Thind, Kevin Zbuk
Journal of Reproductive Immunology|July 1, 2015
The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in peri-implant decidua by 5 weeks' gestationDavid A Clark, Jorge L Arredondo, Sukhbinder Dhesy-Thind
Journal of Reproductive Immunology|June 12, 2016
Corrigendum to "The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in peri-implant decidua by 5 weeks' gestation" [J. Reprod. Immunol. 112 (2015) 20-23]David A Clark, Jorge L Arredondo, Sukhbinder Dhesy-Thind
Clinical Chemistry and Laboratory Medicine|December 8, 2024
Concentrations and agreement over 10 years with different assay versions and analyzers for troponin T and N-terminal pro-B-type natriuretic peptidePeter A Kavsak, Lorna Clark, Andrew Worster, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 22, 2014
The CD200-tolerance signaling molecule associated with pregnancy success is present in patients with early-stage breast cancer but does not favor nodal metastasisDavid A Clark, Sukhbinder Dhesy-Thind, Peter Ellis, et al.
The Breast Journal|July 3, 2019
Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical OncologistsElysia Donovan, Sukhbinder Dhesy-Thind, Som Mukherjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2017
Reply to T.J. Powles et alSukhbinder Dhesy-Thind, Glenn G Fletcher, Mark Clemons, et al.
Pageof 4